Taipei, Taiwan

Wen-Chang Chen

This inventor holds 18 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Nanotechnology Applications. Top assignees: National Taiwan University, Taigen Biotechnology Company, Ltd., Apex Biotechnology Corporation. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Chang Chen. Retrieved from https://idiyas.com/inventor/wen-chang-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 72.2


 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 98(Granted Patents)


Location History:

  • Yilan, TW (2019)
  • Taipei, TW (2002 - 2023)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nanofiber
Photovoltaic Device
Metal Nanowires
Flame-Retardant
Heterocyclic Compounds
Polyimide
Epoxy Resin
Conductive Polymer
Peptide Inhibitors
Inorganic Nanoparticles
Test Strip
Biosensor
18 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Wen-Chang Chen

Introduction

Wen-Chang Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of materials science and electronics, holding a total of 17 patents. His work focuses on developing advanced materials and processes that have the potential to revolutionize various applications in technology.

Latest Patents

One of his latest patents is a polyimide-based copolymer and electronic component, which includes a field effect transistor. This invention provides a novel polyimide-based copolymer that comprises a copolymer of dianhydride and heterocyclic diamine. The heterocyclic diamine features two benzene rings, with ether and thioether bonds connecting them. This innovative copolymer exhibits excellent thermal-mechanical stability and shows promise for use as a substrate in flexible electronics. Another significant patent involves the stereoselective synthesis of an intermediate for the preparation of a heterocyclic compound, which acts as a Cap-dependent endonuclease inhibitor. This synthesis process is characterized by its simplicity, higher yield, and controllable stereoselectivity, making it suitable for large-scale production.

Career Highlights

Wen-Chang Chen has worked with esteemed institutions such as National Taiwan University and Taigen Biotechnology Company, Ltd. His experience in these organizations has allowed him to further his research and development efforts in innovative technologies.

Collaborations

Throughout his career, Wen-Chang Chen has collaborated with notable colleagues, including Wen-Yen Chiu and Hong-Ming Lin. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Wen-Chang Chen's contributions to the field of materials science and electronics are noteworthy. His innovative patents and collaborations highlight his commitment to advancing technology and improving applications in various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…